PA
Profund Advisors Portfolio holdings
AUM
$2.78B
This Quarter Return
+9.15%
1 Year Return
+29.53%
3 Year Return
+153.44%
5 Year Return
+262.59%
10 Year Return
+738.89%
AUM
$2.11B
AUM Growth
+$2.11B
(+20%)
Cap. Flow
+$219M
Cap. Flow
% of AUM
10.41%
Top 10 Holdings %
Top 10 Hldgs %
27.96%
Holding
1,348
New
141
Increased
948
Reduced
208
Closed
51
Top Buys
| 1 |
Alphabet (Google) Class A
GOOGL
|
$22.8M |
| 2 |
Apple
AAPL
|
$6.17M |
| 3 |
Microsoft
MSFT
|
$5.29M |
| 4 |
Intel
INTC
|
$5.24M |
| 5 |
Meta Platforms (Facebook)
META
|
$4.59M |
Top Sells
| 1 |
Alphabet (Google) Class C
GOOG
|
$15.1M |
| 2 |
Biogen
BIIB
|
$2.68M |
| 3 |
YGE
Yingli Green Energy Holding Comp
YGE
|
$2.22M |
| 4 |
CMCSK
COMCAST CORP SPL A (NEW)
CMCSK
|
$1.77M |
| 5 |
Gilead Sciences
GILD
|
$1.71M |
Sector Composition
| 1 | Healthcare | 38.07% |
| 2 | Technology | 12.42% |
| 3 | Communication Services | 8.77% |
| 4 | Consumer Discretionary | 7.64% |
| 5 | Financials | 7.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Gilead Sciences
GILD
$140B
| $113M | 5.34% | 1,112,550 -16,941 | -1% | -$1.71M |
|
2
Amgen
AMGN
$155B
| $94.4M | 4.48% | 581,491 -1,912 | -0.3% | -$310K |
|
|
CELG
3
DELISTED
Celgene Corp
CELG
| $72.7M | 3.45% | 606,633 -1,704 | -0.3% | -$204K |
|
4
AbbVie
ABBV
$372B
| $69.4M | 3.29% | 1,170,995 -22,688 | -2% | -$1.34M |
|
|
5
Biogen
BIIB
$19.4B
| $52.7M | 2.5% | 172,109 -8,739 | -5% | -$2.68M |
|
|
6
Apple
AAPL
$3.45T
| $48M | 2.28% | 455,785 +58,659 | +15% | +$6.17M |
|
7
Amazon
AMZN
$2.44T
| $37M | 1.75% | 54,716 +5,492 | +11% | +$3.71M |
|
|
8
Microsoft
MSFT
$3.77T
| $36.1M | 1.71% | 650,458 +95,364 | +17% | +$5.29M |
|
9
Regeneron Pharmaceuticals
REGN
$61.5B
| $33.3M | 1.58% | 61,385 +762 | +1% | +$414K |
|
|
ALXN
10
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $33.2M | 1.58% | 174,063 +93 | +0.1% | +$17.7K |
|
|
11
Meta Platforms (Facebook)
META
$1.86T
| $28.2M | 1.34% | 269,505 +43,868 | +19% | +$4.59M |
|
12
Johnson & Johnson
JNJ
$427B
| $25.8M | 1.22% | 250,696 -11,643 | -4% | -$1.2M |
|
|
13
Alphabet (Google) Class C
GOOG
$2.58T
| $24.7M | 1.17% | 32,513 -19,957 | -38% | -$15.1M |
|
14
Vertex Pharmaceuticals
VRTX
$100B
| $23.8M | 1.13% | 189,113 +1,006 | +0.5% | +$127K |
|
|
15
Alphabet (Google) Class A
GOOGL
$2.57T
| $22.8M | 1.08% | +29,321 | New | +$22.8M |
|
16
Illumina
ILMN
$15.8B
| $21.7M | 1.03% | 113,138 +3,672 | +3% | +$705K |
|
|
17
Intel
INTC
$107B
| $20.4M | 0.97% | 592,678 +152,218 | +35% | +$5.24M |
|
18
Exxon Mobil
XOM
$487B
| $18.7M | 0.89% | 240,516 +7,326 | +3% | +$571K |
|
19
Pfizer
PFE
$141B
| $17.8M | 0.85% | 552,559 -12,571 | -2% | -$406K |
|
|
BXLT
20
DELISTED
BAXALTA INC COM STK (DE)
BXLT
| $15.2M | 0.72% | 388,909 -944 | -0.2% | -$36.8K |
|
21
Incyte
INCY
$16.5B
| $14M | 0.66% | 128,829 +12,533 | +11% | +$1.36M |
|
22
Merck
MRK
$210B
| $13M | 0.62% | 247,012 -19,639 | -7% | -$1.04M |
|
23
Comcast
CMCSA
$125B
| $12.9M | 0.61% | 228,860 +50,722 | +28% | +$2.86M |
|
24
BioMarin Pharmaceuticals
BMRN
$11.2B
| $12.8M | 0.61% | 121,911 +37 | +0% | +$3.88K |
|
|
AGN
25
DELISTED
Allergan plc
AGN
| $11.1M | 0.53% | 35,555 -1,516 | -4% | -$474K |
|